Analystreport

Mirum Pharmaceuticals (MIRM) had its price target lowered by Royal Bank Of Canada from $130.00 to $128.00. They now have an "outperform" rating on the stock.

Mirum Pharmaceuticals, Inc. - common stock  (MIRM) 
Last mirum pharmaceuticals, inc. - common stock earnings: 3/12 04:02 pm Check Earnings Report